GSK to buy RAPT Therapeutics in $2.2B deal
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — GSK said Tuesday it would buy RAPT Therapeutics in a deal worth $2.2 billion, picking up an experimental medicine for food allergies. GSK is paying $58 per share for the South San Francisco biotech, … [Read more…]